0001800934-20-000002.txt : 20200123 0001800934-20-000002.hdr.sgml : 20200123 20200123142546 ACCESSION NUMBER: 0001800934-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200123 DATE AS OF CHANGE: 20200123 EFFECTIVENESS DATE: 20200123 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Revel Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001800934 IRS NUMBER: 842338101 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-358789 FILM NUMBER: 20541533 BUSINESS ADDRESS: STREET 1: 953 INDIANA STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: 217-766-4292 MAIL ADDRESS: STREET 1: 953 INDIANA STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 D 1 primary_doc.xml X0708 D LIVE 0001800934 Revel Pharmaceuticals Inc. 953 INDIANA STREET SAN FRANCISCO CA CALIFORNIA 94107 217-766-4292 DELAWARE None None Corporation true 2019 Aaron Cravens 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Biotechnology No Revenues 06b false 2019-12-20 false true true false 100000 1600000 533333 1066667 false 2 0 0 158000 Amount represents yearly compensation false Revel Pharmaceuticals Inc. Aaron Cravens Aaron Cravens CEO 2020-01-23